← Leaderboards
Christopher M O'Connor
Duke University
$28,767,454
Attributed
$28,767,454
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$28,069,205 · 3
FDA$698,249 · 1
By mechanism
U01$27,384,160 · 2
R18$698,249 · 1
M01$685,045 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Michael Barry Kastan$65,974,699
- Herbert Kim Lyerly$48,598,090
- Daniel K Benjamin$109,874,279
- Kathleen Mullan Harris$60,779,304
- Kent J. Weinhold$61,568,723
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHeart FailureHuman SubjectCost EffectivenessClinical TrialsTrainingAdverse EventPeptide Hormone AnalogHormone TherapyGrowth Hormone Releasing HormoneHeart Disorder ChemotherapyMortality Vital StatisticsGrantSomatotropinCaringEnrollmentBaseFollow-UpInsulinlike Growth FactorHeart FunctionQuality Of LifeExerciseClinical Trials DesignAncillary Study
Grant awards (21)
The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community$50,000
R18 · FY2024 · FD · contact PI
The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community$499,244
R18 · FY2021 · FD · contact PI
The Heart Failure Collaboratory Public-Private Partnership Between the United States Food and Drug Administration, the Inova Heart and Vascular Institute, and the Heart Failure Community$149,005
R18 · FY2020 · FD · contact PI
Heart Failure Clinical Research Network - RCC$515,791
U01 · FY2011 · HL · contact PI
Heart Failure Clinical Research Network - RCC$516,532
U01 · FY2009 · HL · contact PI
Heart Failure Clinical Research Network - RCC$504,883
U01 · FY2008 · HL · contact PI
ACTION - A CHF Trial Investigating Outcomes of Exercise$446,262
U01 · FY2008 · HL · contact PI
ACTION - A CHF Trial Investigating Outcomes of Exercise$2,338,416
U01 · FY2007 · HL · contact PI
Heart Failure Clinical Research Network - RCC$513,959
U01 · FY2007 · HL · contact PI
ACTION - A CHF Trial Investigating Outcomes of Exercise$3,507,501
U01 · FY2006 · HL · contact PI
Heart Failure Clinical Research Network - RCC$532,143
U01 · FY2006 · HL · contact PI
ACTION - A CHF Trial Investigating Outcomes of Exercise$1,899,053
U01 · FY2005 · HL
ACTION - A CHF Trial Investigating Outcomes of Exercise$5,802,967
U01 · FY2004 · HL
ACTION - A CHF Trial Investigating Outcomes of Exercise$5,752,206
U01 · FY2003 · HL
ACTION - A CHF Trial Investigating Outcomes of Exercise$5,054,447
U01 · FY2002 · HL
PH II: CP 424,391 FOR MILD TO MODERATE HEART FAILURE$117,022
M01 · FY2002 · RR
PH II: CP 424,391 FOR MILD TO MODERATE HEART FAILURE$293,069
M01 · FY2001 · RR
PH II: CP 424,391 FOR MILD TO MODERATE HEART FAILURE$117,022
M01 · FY2001 · RR
PH II: CP 424,391 FOR MILD TO MODERATE HEART FAILURE$117,022
M01 · FY2001 · RR
PH II: CP 424,391 FOR MILD TO MODERATE HEART FAILURE$40,910
M01 · FY2000 · RR
PH II: CP 424,391 FOR MILD TO MODERATE HEART FAILURE$0
M01 · FY2000 · RR